Read DIR Opportunities: Research and Training Programs For

Total Page:16

File Type:pdf, Size:1020Kb

Read DIR Opportunities: Research and Training Programs For OPPORTUNITIES Research and Training Programs for 2019-2020 NIAID Division of Intramural Research NIAID National Institute of Allergy and Infectious Diseases U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health OPPORTUNITIES Research and Training Programs for 2019-2020 NIAID Division of Intramural Research NIAID U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health NIH Publication No. 15-4948 August 2019 CONTENTS Introduction ................................................ 2 About DIR .................................................. 4 Unparalleled Opportunities .................................. 5 World-Class Facilities and Research Support ................... 5 International Research ..................................... 6 The Edge of Scientific Discovery ............................. 6 Collaborative Research ..................................... 7 DIR Training Programs ....................................... 8 Postdoctoral Training ..................................... 10 Predoctoral Training for Students............................ 12 Clinical Training Opportunities ............................... 14 Allergy and Immunology Training Program..................... 17 Infectious Diseases Fellowship Program ...................... 18 NIAID Transition Program in Clinical Research ................. 18 Loan Repayment Programs .................................. 20 General Research Intramural Loan Repayment Program .......... 20 AIDS Research Intramural Loan Repayment Program ............ 21 Clinical Research Loan Repayment Program for Individuals From Disadvantaged Backgrounds ............................. 21 ACGME Fellows Loan Repayment Program .................... 21 General Requirements for Loan Repayment Programs ........... 21 Tenure and Tenure Track at NIAID ............................ 22 Tenure / Non-Tenure ........................................ 23 DIR Branches .............................................. 25 Comparative Medicine Branch . 26 Research Technologies Branch .................................. 28 Rocky Mountain Veterinary Branch .............................. 34 DIR Laboratories and Independent Sections ................... 37 Laboratory of Allergic Diseases ................................. 38 Laboratory of Bacteriology ..................................... 42 Laboratory of Clinical Immunology and Microbiology ................ 48 Laboratory of Immunogenetics .................................. 59 Laboratory of Immune System Biology ............................ 64 Laboratory of Immunoregulation. 71 Laboratory of Infectious Diseases ............................... 77 Laboratory of Malaria Immunology and Vaccinology ................. 82 Laboratory of Malaria and Vector Research........................ 85 Laboratory of Molecular Immunology ............................. 91 Laboratory of Molecular Microbiology ............................ 94 Laboratory of Parasitic Diseases ................................ 97 Laboratory of Persistent Viral Diseases .......................... 103 Laboratory of Viral Diseases................................... 107 Laboratory of Virology........................................ 111 Viral Immunology Section..................................... 114 Molecular HIV Host Interactions Section ......................... 115 Acronyms ................................................ 117 Index .................................................... 118 Photo Credits ............................................. 123 4ii NIAID DIVISION OF INTRAMURAL RESEARCH ORGANIZATIONAL CHART OFFICE OF THE DIRECTOR, DIR Laboratory of Laboratory of Comparative Laboratory of Laboratory of Laboratory of Laboratory of Clinical Immunology Immune System Medicine Branch Allergic Diseases Bacteriology Immunogenetics Immunoregulation and Microbiology Biology Laboratory Laboratory of Laboratory of Laboratory Laboratory Laboratory of Laboratory of of Infectious Malaria and Malaria Immunology of Molecular of Molecular Persistent Viral Parasitic Diseases Diseases Vector Research and Vaccinology Immunology Microbiology Diseases Research Molecular HIV Laboratory of Viral Laboratory of Rocky Mountain Viral Immunology Technologies Host Interactions Diseases Virology Veterinary Branch Section Branch Section Office of Office of Scientific Office of Training Operations and Management and Diversity Management ABOUT DIR 11 INTRODUCTION TO NIAID 2 GREETINGS from the Division of Intramural Research (DIR) at the National Institute of Allergy and Infectious Diseases (NIAID). For more than 60 years, our twin campuses in Bethesda, Maryland, and Hamilton, Montana, have been home to exceptional scientists conducting integrated basic and clinical research in immunology, allergy, and infectious diseases. DIR researchers continue to discover new pathogens, decipher new immune system functions, identify new mechanisms of allergy and immunological diseases, and develop new FDA-approved vaccines and therapies. Technological advances in imaging, structural biology, systems biology, and the “-omics” help DIR pry into the innermost workings of the immune system and its pathogens and to search out their interactions. We are making game-changing discoveries that address our mission to develop and improve diagnostics, drugs, and vaccines. Training is a central theme in DIR. We seek the best and brightest talent for our laboratories and clinical research programs, at all stages of their careers. Our programs range from summer internships for high school and college students to postbaccalaureate and postdoctoral training experiences and accredited medical fellowships in allergy/immunology and infectious diseases. Our trainees work side-by-side with outstanding scientists and trainees from every part of the world. DIR investigators are leaders in their fields, recognized by extensive publications and prestigious awards. Our international programs offer chances to gain valuable field experience in malaria, tuberculosis, and tropical diseases. To do this, our research facilities include high-containment laboratories; advanced instrumentation; a robust animal program; and the NIH Clinical Center, the world’s largest hospital devoted exclusively to clinical investigation. We invest in our trainees’ careers by providing mentored research experiences, skill-building workshops, grant-writing seminars, special interest groups, scientific lectures, and individual counseling. We seek to make you the best you can be at whatever you decide to be, whether in research, academia, industry, or regulation. In addition, we have staff, tenure-track, and tenured positions. Please take some time to learn more about DIR investigators and their laboratories. Don’t hesitate to reach out to us directly or to any investigator as you go through the next days. This is where we work on the science and medicine of tomorrow, today. L: Steven M. Holland, M.D., Director, Division of Intramural Research, NIAID R: Karyl S. Barron, M.D., Deputy Director, Division of Intramural Research, NIAID INTRODUCTION 3 ABOUT DIR WE BEGAN in 1887, as a one- person lab housed in the attic of the Staten Island Marine Hospital in New York. Now, the National Institutes of Health (NIH) encompasses 27 Institutes and Centers and a budget of more than $30 billion. The National Institute of Allergy and Infectious Diseases (NIAID) is one of the largest basic and clinical research Institutes at NIH. The Division of Intramural Research (DIR) is a major component of NIAID. Our focus is on the patients who have infectious, immune, and allergic diseases and the basic science that promotes the development of new therapeutics, diagnostics, and vaccines. In pursuit of these goals, DIR researchers do the following: • Admit and treat patients with diseases under study, ranging from HIV to tuberculosis to rare immune deficiencies and allergic diseases • Expand knowledge of immune-system components and functions • Define mechanisms responsible for immunodeficiency, allergy, and autoimmunity • Study the biology of infectious agents (viruses, bacteria, fungi, and parasites) and the host responses to them • Develop novel strategies to prevent and treat immunologic, allergic, and infectious diseases DIR scientists study all aspects of infectious diseases, including causative agents, vectors, and pathogenesis in humans and animals. Clinical research informs and responds to key lab discoveries, allowing for rapid translation into disease prevention, diagnosis, and treatment. DIR alone has more than 120 active clinical trials at the NIH Clinical Center, Bethesda, Maryland, as well as others at collaborating U.S. and international sites. 4 Unparalleled Opportunities DIR is home to a vibrant research community of about 120 principal investigators who lead about 1,200 colleagues composed of scientists, physicians, trainee fellows, technical personnel, and students. DIR principal investigators are distinguished in their fields, as reflected in their preeminent publications, their numerous awards, and their election to prestigious societies, including the U.S. National Academies of Sciences and Medicine. Trainees, both pre- and postdoctoral physicians and scientists, constitute the largest staff group in DIR. DIR is collegial, open, and collaborative. At the heart of the NIH campus is the NIH Clinical Center, a unique hospital devoted to performing clinical research while providing outstanding care. Our research facilities are within and adjacent to the hospital and provide access to state-of-the-art
Recommended publications
  • Lshtm-Prospectus.Pdf
    Welcome The London School of Hygiene & Tropical Medicine (LSHTM) is widely recognised as a world-leading school of public and global health, working closely with partners in the UK and worldwide to address contemporary and future critical health challenges. Our commitment to improving Professor Peter Piot KCMG FMedSci health in the UK and worldwide is the lifeblood of LSHTM, and I am proud Peter Piot is the Director and Handa Contents of the work our staff, students and Professor of Global Health at the alumni do to address major health London School of Hygiene & Tropical inequalities and challenges. Medicine. Professor Piot was part of a team that co-discovered the Ebola INTRODUCTION 03 COURSES 16 We have a diverse and truly global community dedicated virus in 1976, and was a leading voice to quality cross-disciplinary research. LSHTM is involved during the recent Ebola outbreak in at every stage of the research pipeline, from basic science West Africa. He also instigated some Welcome 03 Clinical Trials 16 all the way through to evaluation of health interventions, of the first research programmes Why Choose LSHTM? 04 Epidemiology 18 providing a firm foundation of evidence for improving health. into HIV/AIDS, and was the founding Crucially, we take research out into the real world to make Executive Director of UNAIDS and Why Distance Learning? 05 Global Health Policy 20 a tangible difference in people’s lives. Under-Secretary-General of the LSHTM and University of London 06 Infectious Diseases 22 United Nations from 1995 until 2008. This year marks our School’s 120th anniversary and we Our Global Student Community 08 Public Health 24 are celebrating 120 years of health innovation at LSHTM.
    [Show full text]
  • Travel Clinic Operations Guide Edition 5
    Travel Clinic Operations Guide Edition 5 www.travax.com © 2016 Shoreland, Inc. All rights reserved. Travel Clinic Operations Guide – page 2 INTRODUCTION The Travel Clinic Operations Guide provides an overview of the resources and travel-specific information useful to those starting and maintaining an international travel medicine clinic or administering travel-related vaccines within the context of a medical practice. Additional considerations may apply to travel medicine clinics in other care delivery settings such as pharmacies, workplaces, and public health departments. Non-physician prescription of vaccines or travel-related medication is increasingly common, but varies widely by state or province, and local regulations need to be clearly understood. Materials have been designed to help standardize delivery of service and reduce administrative workload. This guide focuses on aspects of clinic operations that are unique to the practice of travel medicine. Resources, policies and procedures, and other guidelines applicable to general medical clinics can be found in a multitude of other publications and will not be provided here. ESTABLISHING A TRAVEL HEALTH CLINIC THE BASICS Because the concept of travel medicine is often new to travelers, it is important to take into consideration the unique aspects of establishing a travel medicine clinic. Location: A highly visible location on a main floor or centralized location will generate interest, prompt inquiries, and encourage drop- ins. A location within a well-care setting is also desirable. Parking: Because many travel medicine clinics offer evening or weekend appointments for busy travelers, parking should be both easily accessible and safe. Naming: Clinic names and signs should clearly indicate the unique services offered, such as travel immunizations.
    [Show full text]
  • Ctropmed® Examination)
    Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health (CTropMed® Examination) Striving for Professional Excellence in Clinical Tropical Medicine and Travelers’ Health October 11–24, 2021 NEW IN 2021! The CTropMed® Examination is being offered globally through secure internet-based testing sites. Visit the list of testing centers here. Download Sample Exam Questions #TropMed21 Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health (CTropMed® Examination) New in 2021! The CTropMed® Examination is being offered globally through secure internet-based testing sites. Visit the list of testing centers here. Table of Contents Fostering professional development in the fields of clinical tropical medicine and Requirements................. 3 travelers’ health is one of the Society’s highest priorities. To that end, ASTMH About the Examination .......... 5 developed the Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Applying for the Examination ..... 5 Health (CTropMed® Examination) as a means to distinguish individuals who have Testing Centers ............... 6 demonstrated advanced knowledge and experience in these fields. The Certificate Test Center Admission of Knowledge in Clinical Tropical Medicine and Travelers’ Health is conferred on Requirements................. 7 Prohibited Items............... 8 1) licensed healthcare professionals applying via Practice Pathway or those Cancellation and healthcare professionals (regardless of licensure) who have passed an ASTMH- Rescheduling Policy............ 9 accredited Diploma Course, 2) have direct experience in the fields of tropical Scoring ..................... 10 medicine and/or travelers’ health, and 3) have passed the ASTMH Examination in Examination Results............ 10 Clinical Tropical Medicine and Travelers’ Health. Special Circumstances.......... 10 ASTMH’s Committment to Inclusion and Respect .......... 11 To support this process, ASTMH accredits specific diploma courses that meet Examination Checklist .........
    [Show full text]
  • Programme Specification
    PROGRAMME SPECIFICATION 1. Overview Academic Year 2020-21 (student cohorts covered by specification Programme Title Immunology of Infectious Diseases Programme Director Gregory Bancroft Awarding Body University of London Teaching Institution London School of Hygiene & Tropical Medicine Faculty Infectious and Tropical Diseases Length of MSc – Full time = 12 months, Split study = 24 months Programme (months) Entry Routes MSc Exit Routes MSc/PGDip/PGCert Award Titles MSc in Immunology of Infectious Diseases (180 credits) Exit awards: PGDip in Immunology of Infectious Diseases (120 credits) PGCert in Immunology of Infectious Diseases (60 credits) Accreditation by N/A Professional Statutory and Regulatory Body Relevant PGT QAA No relevant PGT QAA benchmark for this MSc Benchmark Programme. Statement and/or other external/internal reference points Level of programme Masters (MSc) Level 7 within the Framework for Higher Education Qualifications (FHEQ) Total Credits CATS: 180 ECTS: 90 HECoS Code(s) 100345:100265:100948 (1:1:1) Mode of Delivery For 2020-21, the delivery of LSHTM teaching has been adjusted in response to the COVID-19 pandemic. For MSc Immunology of Infectious Diseases: Term 1 core module teaching will be delivered online only, with a combination of synchronous (live and interactive) and asynchronous (recordings, independent study, individual exercises, etc) activities. Terms 2 modules will be offered both online and also on-campus where possible. Some on-campus modules will use a blended approach of both face to face and online delivery if permitted under UK social distancing rules at that time. Term 3 will include on-campus pre- project lab training and access for students undertaking lab-based projects.
    [Show full text]
  • Traveling Outside the United States? Get Vaccinated. Vaccines Protect You from Diseases Not Often Found in the United States
    Traveling outside the United States? Get vaccinated. Vaccines protect you from diseases not often found in the United States. Plan ahead for safe, healthy travel. Get vaccinated 2 months before your trip. • Contact your healthcare provider or a travel clinic or pharmacy below. • Vaccines take time to fully protect you. • You may need multiple doses of vaccine, up to 4 weeks apart. Some travelers have special needs to consider. General information may not apply to your health situation or travel plans. You may need to schedule a consultation to determine how you should prepare for safe travel. Especially if you are: • Older than 65. • Traveling with a child younger than 2. • Pregnant. • Living with a medical condition. Online resources • Taking certain medications. Call before you go to Travel Health Online verify services and fees. tripprep.com Travel clinics Centers for Disease Control and Prevention Travelers’ Health Passport Health Virginia Mason Travel Clinic cdc.gov/travel 4301 S. Pine St., Suite 27 33501 First Way S. United States Department of State Tacoma, 98409 Federal Way, 98003 Travel Information (206) 414-2709 (206) 583-6585 travel.state.gov passporthealthusa.com virginiamason.org/travel-health World Health Organization International Travel and Health Pharmacies who.int/health-topics/travel-and-health International Society of Travel Medicine Rite Aid Fred Meyer istm.org Gig Harbor....(253) 851-6939 Bonney Lake ........(253) 891-7333 American Journal of Tropical Medicine Lakewood ....(253) 588-3666 Puyallup................(253) 840-8183 and Hygiene Tacoma .........(253) 474-0115 Sumner .................(253) 826-8433 ajtmh.org Tacoma .................(253) 475-6073 Safeway University Place ...(253) 460-4033 Milton ...........(253) 952-0390 Puyallup........(253) 841-1534 Tacoma .........(253) 566-9217.
    [Show full text]
  • Glossary of Acronyms
    Glossary of Acronyms Ab Antibody AFRO World Health Organization Regional Office for Africa ALB, Alb Albendazole AMRO World Health Organization Regional Office for the Americas (see PAHO) APOC World Health Organization African Programme for Onchocerciasis Control BICO Blantyre Institute for Community Opthamology BMGF Bill & Melinda Gates Foundation CAR Central African Republic CCA Circulating Cathodic Antigen CDC U.S. Centers for Disease Control & Prevention CRFilMT Center for Research on Filariasis and Other Tropical Diseases CWW Children Without Worms, The Task Force for Global Health DEC Diethylcarbamazine DOLF Death to Onchocerciasis and Lymphatic Filariasis Project, Washington University in St. Louis DRC Democratic Republic of Congo ELISA Enzyme-Linked Immunosorbent Assay EMRO World Health Organization Regional Office for the Eastern Mediterranean EURO World Health Organization Regional Office for Europe FHI, FHI360 Family Health International FPSU Filarial Programmes Support Unit, Liverpool School of Tropical Medicine (formerly CNTD) FTS Alere Filariasis Test Strip GSK GlaxoSmithKline GTMP Global Trachoma Mapping Project HDI Health and Development International HKI Helen Keller International IBB Institut de Bouisson Bertrand ICT Immunochromatography Test IRD Institut de Recherche pour le Développement ITI International Trachoma Initiative, The Task Force for Global Health IVM, Iver Ivermectin (Generic Name for Mectizan) JCU James Cook University JHU John Hopkins University KEMRI Kenya Medical Research Institute LF Lymphatic Filariasis
    [Show full text]
  • The Educational Background for the Practice of Tropical Medicine
    THE EDUCATIONAL BACKGROUND FOR THE PRAC-. TICE OF TROPICAL MEDICINE' FREDERICK F. RUSSELL From the International Health Board, Rockefeller Foundation, New York, N. Y. Received for publication November 14, 1934 My address wifi be brief, as I have really a very simple theme and it will not take much of your time for me to present it. It is unnecessary for me to remind you that we are living in a changing world, and that both medicine and public health are playing a much more important role in the world than they did formerly. For example, it is now customary for public officials and people in general to talk about adequate medical care for every one; this is no longer merely the dream of the sociologist, but a real objective of the thinking public. I imagine that most of us, of the older generation, realize that this is a very high ideal, which has never yet been reached, even in the most advanced countries. It predicates further the utmost use of preventive as well as of curative medicine, otherwise the ideal could never be even remotely approached. The problem and the objective have recently been stated by Dean John Wyckoff of the New York University Medical School as follows: “Adequatemedical attention should be available to the public to the same extent as educational facffities.― You are no doubt familiar with the statements of Sir George Newman, Principal Medical Officer of Great Britain, who as an expert in medical education has coined the happy phrase that “themedical curriculum must be permeated with public health.― If this be the present attitude of educators, sociologists, and the leaders of the medical profession in the most advanced countries may we not ask and try to learn how it affects us in our special 1Pr@ident's address delivered at the thirtieth annual meeting of the Ameri can Society of Tropical Medicine, at San Antonio, Texas, November 15, 1934.
    [Show full text]
  • GLOSSARY of TERMS WHO European Primary Health Care Impact, Performance and Capacity Tool (PHC-IMPACT)
    GLOSSARY OF TERMS WHO European Primary Health Care Impact, Performance and Capacity Tool (PHC-IMPACT) WHO European Framework for Action on Integrated Health Services Delivery Glossary of terms WHO European Primary Health Care Impact, Performance and Capacity Tool (PHC-IMPACT) Series editors Juan Tello, WHO Regional Office for Europe Erica Barbazza, University of Amsterdam Zhamin Yelgezekova, WHO European Centre for Primary Health Care Ioana Kruse, WHO European Centre for Primary Health Care Niek Klazinga, University of Amsterdam Dionne Kringos, University of Amsterdam WHO European Framework for Action on Integrated Health Services Delivery Abstract This glossary of terms aims to provide clarifying definitions related to the WHO European Primary Health Care Impact, Performance and Capacity Tool (PHC-IMPACT). PHC-IMPACT sets out to support the monitoring and improvement of primary health care in the European Region and the measurement of progress towards the services delivery component of global universal health coverage targets. The framework underpinning PHC-IMPACT has been guided by the WHO European Framework for Integrated Health Services Delivery. This glossary of terms accompanies PHC-IMPACT’s Indicator Passports – a resource providing detailed information for the use of the full suite of indicators that make up the tool. Importantly, the definitions included here have relied as far as possible on existing international classifications including the International Classification for Health Accounts, International Standard Classification of Occupations and International Standard Classification of Education. Keywords HEALTH SERVICES PRIMARY HEALTH CARE HEALTH CARE SYSTEMS HEALTH POLICY EUROPE Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office website (http://www.euro.who.int/pubrequest).
    [Show full text]
  • A Brief History of Global Health by M
    An Introduction to Global Health and Global Health Ethics: A Brief History of Global Health By M. A. Palilonis Learning Objectives: 1. Identify population-level and individual-level health measures across the history of global health 2. Consider competing theories of justice in global health 3. Evaluate the arguments for and against wealthy nations to provide international aid A Brief History of Global Health In order to understand a broad concept, like global health, it is important to consider where it comes from. The history of global health will be told here in broad strokes and will follow two major trends that shaped global health organizations: population health through the control of infectious diseases and individual health through the delivery of healthcare. Each of the stages discussed here, tropical medicine, international health, the age of development and the rise of the NGO, overlap and converge. Overall, as the world became increasingly interconnected global health moved from the imperial concerns of “tropical medicine” to include more nations and other international organizations in the formations of international health policy. However, though the concept of global health changed greatly since its beginning, infection control and delivery of healthcare remained important core features of global health. Tropical Medicine This stage of global health is defined by the imperial system of colonization. In the 16th and 17th centuries European countries began to travel to new lands setting up the settlements that would eventually become the colonies of the 18th and 19th centuries. Countries such as Great Britain, France and Portugal founded colonies in places such as India, China and Africa, where settlers encountered new diseases and harsh climates.i Infectious diseases were devastating to both the native populations and to the European colonists.
    [Show full text]
  • Travel Medicine What’S Involved? When to Refer?
    Clinical Review Travel medicine What’s involved? When to refer? Brian Aw MD CCFP Suni Boraston MD MHSc David Botten MD CCFP Darin Cherniwchan MDCM CCFP FCFP Hyder Fazal MD FRCPC Timothy Kelton MD CCFP(EM) FCFP Michael Libman MD FRCPC Colin Saldanha MBBS Philip Scappatura MD Brian Stowe MBA Abstract Objective To defne the practice of travel medicine, provide the basics of a comprehensive pretravel consultation for international travelers, and assist in identifying patients who might require referral to travel medicine professionals. Sources of information Guidelines and recommendations on travel medicine and travel-related illnesses by national and international travel health authorities were reviewed. MEDLINE and EMBASE searches for related literature were also performed. Main message Travel medicine is a highly dynamic specialty that focuses on pretravel preventive care. A comprehensive risk assessment for each individual traveler is essential in order to accurately evaluate traveler-, itinerary-, and destination-specifc risks, and to advise on the most appropriate risk management interventions to promote EDITOR’S KEY POINTS health and prevent adverse health outcomes during travel. • Travel medicine is a multidisciplinary specialty Vaccinations might also be required and should be personalized that requires expertise in travel-related according to the individual traveler’s immunization history, travel illnesses, as well as up-to-date knowledge itinerary, and the amount of time available before departure. of the global epidemiology of infectious and noninfectious health risks, health regulations Conclusion A traveler’s health and safety depends on a and immunization requirements in various practitioner’s level of expertise in providing pretravel counseling countries, and the changing patterns of drug- and vaccinations, if required.
    [Show full text]
  • Hydroxychloroquine Prophylaxis and Treatment Is Ineffective in Macaque and Hamster SARS-Cov-2 Disease Models
    Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models Kyle Rosenke, … , Emmie de Wit, Heinz Feldmann JCI Insight. 2020. https://doi.org/10.1172/jci.insight.143174. Research In-Press Preview COVID-19 Therapeutics Graphical abstract Find the latest version: https://jci.me/143174/pdf 1 Title: Hydroxychloroquine Prophylaxis and Treatment is Ineffective in Macaque and Hamster 2 SARS-CoV-2 Disease Models 3 4 Authors: Kyle Rosenke,1† Michael. A. Jarvis,2† Friederike Feldmann,3† BenJamin. Schwarz,4 5 Atsushi Okumura,1 JamieLovaglio,3 Greg Saturday,3 Patrick W. Hanley,3 Kimberly Meade- 6 White,1 Brandi N. Williamson,1 Frederick Hansen,1 Lizette Perez-Perez,1 Shanna Leventhal,1 7 Tsing-Lee Tang-Huau,1 Julie Callison,1 Elaine Haddock.1 Kaitlin A. Stromberg,4 Dana Scott,3 8 Graham Sewell,5 Catharine M. Bosio,4 David Hawman,1 Emmie de Wit,1 Heinz Feldmann1* 9 †These authors contributed equally 10 11 Affiliations: 1Laboratory of Virology, 3Rocky Mountain Veterinary Branch and 4Laboratory of 12 Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious 13 Diseases, National Institutes of Health, Hamilton, MT, USA; 14 2University of Plymouth; and The Vaccine Group Ltd, Plymouth, Devon, UK; 15 5The Leicester School of Pharmacy, De Montfort University, Leicester, UK 16 17 *Corresponding author: Heinz Feldmann, Rocky Mountain Laboratories, 903 S 4th Street, 18 Hamilton, MT, US-59840; Tel: (406)-375-7410; Email: [email protected] 19 20 Conflict of Interest Statement: The authors have declared that no conflict of interest exists. 21 22 ABSTRACT 23 We remain largely without effective prophylactic/therapeutic interventions for COVID-19.
    [Show full text]
  • CV Heinz Feldmann
    Curriculum Vitae M.D., Ph.D. Heinz Feldmann Name: Heinz Feldmann Forschungsschwerpunkte: hochinfektiöse Viren, Ebola-Virus, Marburg-Virus, Krankheitsmodellierung mit nichtmenschlichen Primatenmodellen, Entwicklung von Impfstoffen, Ebola-Impfstoff (rVSV-ZEBOV), Virostatika und Therapeutika Heinz Feldmann ist Virologe. Er erforscht hochinfektiöse Viren wie das Lassa-, Ebola- oder Marburg- Virus. Sein Forschungsinteresse gilt der Entwicklung von Impfstoffen. Er hat einen Impfstoff für Ebola entwickelt und gilt als international führender Ebola-Experte. Bei Ausbrüchen von Ebola, Lassa-Fieber und SARS war er vielfach Berater der WHO vor Ort. Akademischer und beruflicher Werdegang seit 2017 Graduate Faculty Associate an der Marshall University, Huntington, West Virginia, USA 2012 - 2017 Affiliate Appointment an der Washington University, Seattle, Washington, USA 2011 - 2015 Graduate Faculty an der Purdue University, West Lafayette, Indiana, USA 2010 - 2018 Faculty Affiliate an der University of Montana, Missoula, Montana, USA seit 2008 Leiter des Laboratory of Virology, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, Montana, USA und Leitender Wissenschaftler der RML BSL4 Laboratories 2002 - 2012 Adjunct Professor am Department of Pathology an der University of Texas Medical Branch, Galveston, Texas, USA seit 1999 Assistant und Associate Professor am Department of Medical Microbiology, Medical Faculty an der University of Manitoba, Winnipeg, Manitoba,
    [Show full text]